◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

HomeAll stocksT › TET

Treatt plc (TET) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Basic Materials · Specialty Chemicals · DATA UPDATED 2026-08-16

Treatt plc (TET) operates in the Specialty Chemicals industry and is headquartered in Bury Saint Edmunds, United Kingdom with about 360 employees. Its market capitalization is roughly £180 million. In the fiscal year ended 2025-09-30, TET reported £132M in revenue and £5M in net income.

Treatt plc, together with its subsidiaries, manufactures and supplies various natural extracts for beverage, flavor, and fragrance markets in the United Kingdom, Germany, Ireland, Europe, the United States, China, and internationally.

Interactive charts & full statements →

TET Revenue & Earnings History — Annual Income Statement

Income statement2025-09-302024-09-302023-09-302022-09-302021-09-30
Total Revenue£132M£150M£147M£140M
Gross Profit£34M£44M£45M£39M
Operating Income (EBIT)£10M£19M£18M£16M
Net Income£5M£14M£11M£13M

GBP; £M / £B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

TET Free Cash Flow History

Cash flow2025-09-302024-09-302023-09-302022-09-302021-09-30
Dividends Paid(£5M)(£5M)(£5M)(£5M)

GBP; £M / £B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

TET Balance Sheet History

Balance sheet2025-09-302024-09-302023-09-302022-09-302021-09-30
Total Assets£169M£169M£175M£188M
Total Liabilities£34M£28M£38M£54M

GBP; £M / £B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive TET viewer.

Other Companies in Specialty Chemicals

← TERAll “T” companiesTEVA →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.